tiprankstipranks
Trending News
More News >
Allovir Inc (ALVR)
NASDAQ:ALVR
US Market
Advertisement

AlloVir (ALVR) Price & Analysis

Compare
342 Followers

ALVR Stock Chart & Stats


Financials

Ownership Overview

Currently, No data available
---

ALVR FAQ

What was Allovir Inc’s price range in the past 12 months?
Allovir Inc lowest stock price was $7.96 and its highest was $24.15 in the past 12 months.
    What is Allovir Inc’s market cap?
    Allovir Inc’s market cap is $30.20M.
      When is Allovir Inc’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Allovir Inc’s earnings last quarter?
      Currently, no data Available
      Is Allovir Inc overvalued?
      According to Wall Street analysts Allovir Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Allovir Inc pay dividends?
        Allovir Inc does not currently pay dividends.
        What is Allovir Inc’s EPS estimate?
        Allovir Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Allovir Inc have?
        Allovir Inc has 5,043,357 shares outstanding.
          What happened to Allovir Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Allovir Inc?
          Currently, no hedge funds are holding shares in ALVR

          Company Description

          Allovir Inc

          AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6.
          Similar Stocks
          Company
          Price & Change
          Follow
          Sangamo Biosciences
          Bluebird Bio
          Fate Therapeutics
          Iovance Biotherapeutics
          Adaptimmune Therapeutics
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis